{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:05:11Z","timestamp":1783382711401,"version":"3.54.6"},"reference-count":43,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Madrid Society of Pneumology and Thoracic Surgery (Neumomadrid)","award":["14000"],"award-info":[{"award-number":["14000"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Vitamin D deficiency has been associated with an accelerated deterioration in lung function and increased exacerbations in chronic obstructive pulmonary disease (COPD). 25(OH) vitamin D levels have been indicated as a potentially useful marker for adverse results related to COPD. Methods: VITADEPOC is a cross-sectional clinical study recruiting consecutive patients with high-risk COPD. The objective of our study was to investigate vitamin D determination frequency in patients with high-risk COPD in clinical practice at outpatient clinics in Spain and to describe the factors associated with vitamin D testing. We also aimed to determine the frequency of vitamin D deficiency in these patients. Results: Only 51 (44%) patients underwent vitamin D determination and 33 (28.4%) had received vitamin D supplements in clinical practice. The patients who underwent testing for vitamin D in clinical practice were more often women (58.8% vs. 26.2%, p &lt; 0.001) with comorbidities such as osteoporosis (19.6% vs. 6.2%, p &lt; 0.001) or chronic renal failure (7.8% vs. 0%, p &lt; 0.001) and with exacerbator phenotype (55% vs. 32.3%, p = 0.015). A total of 63 (54.3%) patients had serum vitamin D levels &lt;20 ng\/mL at the inclusion visit. Of these, 29 (46%) had serum vitamin D levels &lt;12 ng\/mL (severe deficiency). Having a history of inhaled corticosteroids (OR 3.210, p &lt; 0.016), being treated with a cycle of systemic corticosteroids (OR 2.149, p &lt; 0.002), and having a lower physical activity level (OR 3.840, p &lt; 0.004) showed a statistically significant positive association with vitamin D deficiency. Conclusion: The testing of vitamin D levels in patients with high-risk COPD treated at outpatient respiratory clinics in Spain is infrequent. However, when tested, a severe deficiency is detected in one in four patients. Efforts to optimize case detection in COPD are needed.<\/jats:p>","DOI":"10.3390\/jcm11051347","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T08:17:03Z","timestamp":1646122623000},"page":"1347","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Testing for Vitamin D in High-Risk COPD in Outpatient Clinics in Spain: A Cross-Sectional Analysis of the VITADEPOC Study"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3890-2742","authenticated-orcid":false,"given":"Myriam","family":"Calle Rubio","sequence":"first","affiliation":[{"name":"Pulmonary Department, Research Institute of Hospital Cl\u00ednico San Carlos (IdISSC), 28040 Madrid, Spain"},{"name":"Department of Medicine, Faculty of Medicine, University Complutense of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"\u00c1lvarez-Sala","sequence":"additional","affiliation":[{"name":"Pulmonary Department, Research Institute of Hospital Cl\u00ednico San Carlos (IdISSC), 28040 Madrid, Spain"},{"name":"Department of Medicine, Faculty of Medicine, University Complutense of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"Vargas Centanaro","sequence":"additional","affiliation":[{"name":"Pulmonary Department, Research Institute of Hospital Cl\u00ednico San Carlos (IdISSC), 28040 Madrid, Spain"},{"name":"Department of Medicine, Faculty of Medicine, University Complutense of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5750-1530","authenticated-orcid":false,"given":"Ana Mar\u00eda Humanes","family":"Navarro","sequence":"additional","affiliation":[{"name":"Clinical Management Unit of Medicina Preventiva, Research Institute of Hospital Cl\u00ednico San Carlos (IdISSC), 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0552-2484","authenticated-orcid":false,"given":"Juan Luis Rodr\u00edguez","family":"Hermosa","sequence":"additional","affiliation":[{"name":"Pulmonary Department, Research Institute of Hospital Cl\u00ednico San Carlos (IdISSC), 28040 Madrid, Spain"},{"name":"Department of Medicine, Faculty of Medicine, University Complutense of Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Blasi, F., Cesana, G., Conti, S., Chiodini, V., Aliberti, S., and Fornari, C. (2014). The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: A cohort of hospitalized patients. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101228"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/15412555.2019.1598965","article-title":"Recovery Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease\u2014A Review","volume":"16","author":"Wageck","year":"2019","journal-title":"COPD"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1183\/09031936.00046014","article-title":"Exacerbation frequency and FEV1 decline of COPD: Is it geographic?","volume":"43","author":"Seemungal","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Johansson, G., Mushnikov, V., B\u00e4ckstr\u00f6m, T., Engstr\u00f6m, A., Khalid, J.M., and Wall, J. (2018). Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study. BMC Pulm. Med., 18.","DOI":"10.1186\/s12890-018-0573-0"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.medcli.2018.05.011","article-title":"Colaboradores de GBD en Espa\u00f1a; Lista de colaboradores de GBD en Espa\u00f1a. The burden of disease in Spain: Results from the Global Burden of Disease 2016","volume":"151","author":"Soriano","year":"2018","journal-title":"Med. Clin."},{"key":"ref_6","unstructured":"(2021, December 30). Assessing National Capacity for the Prevention and Control of Noncommunicable Diseases: Report of the 2019 Global Survey. Ginebra: Organizaci\u00f3n Mundial de la Salud. 2020. Licencia: CC BY-NC-SA 3.0 IGO. Disponible en. Available online: https:\/\/www.who.int\/teams\/ncds\/surveillance\/monitoring-capacity\/ncdccs."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.arbres.2021.03.005","article-title":"Spanish COPD Guidelines (GesEPOC) 2021, Updated Pharmacological treatment of stable COPD","volume":"58","author":"Miravitlles","year":"2021","journal-title":"Arch. Bronconeumol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.arbr.2017.11.019","article-title":"Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (Gesepoc): The Epoconsul Study","volume":"54","author":"Soriano","year":"2018","journal-title":"Arch. Bronconeumol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.arbres.2020.08.002","article-title":"GesEPOC 2021, One More Step towards Personalized Treatment of COPD","volume":"57","author":"Miravitlles","year":"2021","journal-title":"Arch. Bronconeumol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1210\/jc.2009-1773","article-title":"Update in vitamin D","volume":"95","author":"Adams","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"E98","DOI":"10.1017\/S0029665112001553","article-title":"Vitamin D status in chronic obstructive pulmonary disease","volume":"71","author":"Baldrick","year":"2012","journal-title":"Proc. Nutr. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0140-6736(13)61647-5","article-title":"Effects of vitamin D supplements on bone mineral density: A systematic review and meta-analysis","volume":"383","author":"Reid","year":"2014","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1080S","DOI":"10.1093\/ajcn\/87.4.1080S","article-title":"Vitamin D deficiency: A worldwide problem with health consequences","volume":"87","author":"Holick","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3390\/nu5072502","article-title":"Vitamin D and immune function","volume":"5","author":"Prietl","year":"2013","journal-title":"Nutrients"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1164\/rccm.200810-1576PP","article-title":"Vitamin D beyond bones in chronic obstructive pulmonary disease: Time to act","volume":"179","author":"Janssens","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/archinternmed.2008.560","article-title":"Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey","volume":"169","author":"Ginde","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.2147\/COPD.S101382","article-title":"The association between vitamin D and COPD risk, severity, and exacerbation: An updated systematic review and meta-analysis","volume":"11","author":"Zhu","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.chest.2019.11.047","article-title":"Associations Among 25-Hydroxyvitamin D Levels Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort","volume":"157","author":"Burkes","year":"2020","journal-title":"Chest"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2147\/COPD.S207400","article-title":"Impact of vitamin D on spirometry findings and quality of life in patients with chronic obstructive pulmonary disease: A randomized, double-blinded, placebo-controlled clinical trial","volume":"14","author":"Mehrdad","year":"2019","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/thoraxjnl-2018-212092","article-title":"Vitamin D to prevent exacerbations of COPD: Systematic review and meta-analysis of individual participant data from randomised controlled trials","volume":"74","author":"Jolliffe","year":"2019","journal-title":"Thorax"},{"key":"ref_23","unstructured":"L\u00f3pez-Campos, J.L., Almagro, P., G\u00f3mez, J.T., Chiner, E., Palacios, L., and Hern\u00e1ndez, C. (2021). En nombre del equipo de trabajo de GesEPOC2021. Spanish COPD Guideline(GesEPOC) Update: Comorbidities, Self-Managementand Palliative Care. Arch. Bronconeumol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.54.7.581","article-title":"Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease","volume":"54","author":"Bestall","year":"1999","journal-title":"Thorax"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1440-2440(04)80010-0","article-title":"Test-retest reliability of four physical activity measures used in population surveys","volume":"7","author":"Brown","year":"2004","journal-title":"J. Sci. Med. Sport"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1183\/09031936.00102509","article-title":"Development and first validation of the COPD Assessment Test","volume":"34","author":"Jones","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.arbres.2017.03.018","article-title":"Spanish COPD guidelines (GesEPOC) 2017. Pharmacological treatment of stable chronic obstructive pulmonary diseare","volume":"53","author":"Miravitlles","year":"2017","journal-title":"Arch. Bronconeumol."},{"key":"ref_29","first-page":"18","article-title":"Vitamin D deficiency and insufficiency in patients with COPD\u2014A systematic review","volume":"6","author":"Mekov","year":"2014","journal-title":"Thorac. Med."},{"key":"ref_30","first-page":"84","article-title":"Recomendaciones de la SEIOMM en la prevenci\u00f3n y tratamiento del d\u00e9ficit de vitamina D","volume":"13","author":"Casado","year":"2021","journal-title":"Rev. Osteoporos Metab. Miner."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/thx.2009.120659","article-title":"Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene","volume":"65","author":"Janssens","year":"2010","journal-title":"Thorax"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/thx.2010.155234","article-title":"Relationship of vitamin D status to adult lung function and COPD","volume":"66","author":"Shaheen","year":"2011","journal-title":"Thorax"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1515\/cclm-2016-1040","article-title":"Temporal and regional variability in the request of Vitamin D from general practitioners in Spain","volume":"55","author":"Salinas","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.amjmed.2018.06.025","article-title":"Reducing Unnecessary Vitamin D Screening in an Academic Health System: What Works and When","volume":"131","author":"Petrilli","year":"2018","journal-title":"Am. J. Med."},{"key":"ref_35","first-page":"254","article-title":"Vitamin D Screening and Supplementation in Community-Dwelling Adults: Common Questions and Answers","volume":"97","author":"LeFevre","year":"2018","journal-title":"Am. Fam. Physician"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Rockwell, M., Kraak, V., Hulver, M., and Epling, J. (2018). Clinical management of low vitamin D: A scoping review of physicians\u2019 practices. Nutrients, 10.","DOI":"10.20944\/preprints201803.0131.v1"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00223-012-9693-3","article-title":"Vitamin D assays: Past and present debates, difficulties, and developments","volume":"92","author":"Fraser","year":"2013","journal-title":"Calcif. Tissue Int."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Mekov, E. (2015). Vitamin D Deficiency and Insufficiency in Hospitalized COPD Patients. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129080"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-112-5-352","article-title":"Glucocorticoid-induced osteoporosis: Pathogenesis and management","volume":"112","author":"Lukert","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/jcb.22645","article-title":"Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)ase) transcription by glucocorticoids: Cooperative effects of the glucocorticoid receptor, C\/EBP beta, and the Vitamin D receptor in 24(OH)ase transcription","volume":"110","author":"Dhawan","year":"2010","journal-title":"J. Cell Biochem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1210\/jc.2011-1600","article-title":"Association of glucocorticoid use and low 25-hydroxyvitamin D levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001\u20132006","volume":"96","author":"Skversky","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S2213-2600(14)70255-3","article-title":"Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): A multicentre, double-blind, randomized controlled trial","volume":"3","author":"Martineau","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.21037\/jtd-20-3221","article-title":"Association of serum vitamin D levels with disease severity, systemic inflammation, prior lung function loss and exacerbations in a cohort of patients with chronic obstructive pulmonary disease (COPD)","volume":"13","author":"Jorde","year":"2021","journal-title":"J. Thorac. Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/5\/1347\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:30:00Z","timestamp":1760135400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/5\/1347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["jcm11051347"],"URL":"https:\/\/doi.org\/10.3390\/jcm11051347","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}